Companies: 48,874 Total Market Cap: 132460447025120.92

Kane Biotech

OTC-KNBIF
Healthcare Biotechnology
Rank #41175
Market Cap 7.15 M
Volume 139,800
Price 0.04
Change (%) 20.52%
Country or region Canada Canada

Kane Biotech's latest marketcap:

7.15 M

As of 05/19/2025, Kane Biotech's market capitalization has reached $7.15 M. According to our data, Kane Biotech is the 41175th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 7.15 M
Revenue (ttm) 1.45 M
Net Income (ttm) 4.24 M
Shares Out 0
EPS (ttm) 0.03
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/22/2025
Market Cap Chart
Data Updated: 05/19/2025

Kane Biotech's yearly market capitalization.

Kane Biotech has seen its market value drop from $11.93 M to $7.15 M since 2020, representing a total decrease of 40.06% and an annual compound decline rate (CAGR) of 11.02%.
Date Market Cap Change (%)
05/19/2025 $7.15 M -7.91%
12/31/2024 $10.51 M 31.63%
12/29/2023 $7.99 M -3.79%
12/30/2022 $8.30 M -40.97%
12/31/2021 $14.06 M 17.84%
12/31/2020 $11.93 M

Company Profile

About Kane Biotech Inc.

Kane Biotech Inc. is a biotechnology company focused on the research, development, and commercialization of innovative technologies and products designed to prevent and remove microbial biofilms. The company operates in Canada and internationally, leveraging its proprietary technologies to address critical healthcare challenges.

Key Technologies

  • coactiv+ Technology: An antimicrobial wound gel platform used in various medical applications.
  • DispersinB Technology: A naturally occurring enzyme that targets bacterial biofilms, aiding in wound and otic infection treatments.

Product Portfolio

  • Revyve: An antimicrobial wound gel designed for effective wound care.
  • DermaKB Brand: Includes shampoos, shampoo bars, and scalp detoxifiers for dermatological health.

Pipeline Developments

  • coactiv+ Antimicrobial Surgical Hydrogel: For surgical and acute wound care.
  • coactiv+ Antimicrobial Wound Rinse: Designed for acute and chronic wounds.
  • coactiv+ Antimicrobial Wound Gel Spray: Suitable for acute/chronic wounds and burns.
  • DispersinB Hydrogel: Targeted at prosthetic joint infections.

Company Background

Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada, and continues to pioneer advancements in biofilm prevention and removal.

Frequently Asked Questions

As of 05/19/2025, Kane Biotech (including the parent company, if applicable) has an estimated market capitalization of $7.15 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Kane Biotech global market capitalization ranking is approximately 41175 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Canada
Founded 2001
IPO Date n/a
Employees n/a
CEO Marc Edwards
Sector Healthcare
Industry Biotechnology
Address 100 Innovation Drive
Winnipeg, R3T 6G2
Canada
Website https://kanebiotech.com
People Also Watch
VRTX
440.66 20.52%
CSL Limited
156.11 20.52%
REGN
596.54 20.52%
KRX-207940
735.02 20.52%